2023-505847-38-00CompletedPhase 1
SAD and MAD study of VES001
Source: EU CTIS (euclinicaltrials.eu) · Last updated 15 Apr 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 78 (actual)
- First submitted
- 28 Aug 2023
- Start date
- 11 Oct 2023
- Lead sponsor
- Insusense ApS
- Diseases
- Frontotemporal dementia
- EU CT number
- 2023-505847-38-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 78
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Human Drug Research | Leiden | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.